Ditchcarbon
  • Contact
  1. Organizations
  2. Hengrui Pharma
Public Profile
Pharmaceutical Preparation Manufacturing
CN
updated 13 days ago

Hengrui Pharma

Company website

Hengrui Medicine Co., Ltd., commonly known as Hengrui Pharma, is a leading biopharmaceutical company headquartered in China (CN). Founded in 1993, Hengrui has established a strong presence in the global pharmaceutical industry, focusing on innovative drug development, manufacturing, and marketing. The company operates extensively across Asia, Europe, and North America, positioning itself as a key player in oncology, anaesthesia, and imaging agents. Hengrui Pharma is renowned for its commitment to research and development, with a diverse portfolio that includes targeted therapies and biologics. Its unique approach to drug formulation and delivery has garnered recognition, contributing to its market leadership. With numerous accolades and a robust pipeline of products, Hengrui continues to advance healthcare solutions, making significant strides in improving patient outcomes worldwide.

DitchCarbon Score

How does Hengrui Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

33

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Hengrui Pharma's score of 33 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.

55%

Let us know if this data was useful to you

Hengrui Pharma's reported carbon emissions

In 2024, Hengrui Pharma reported total carbon emissions of approximately 257,897,240 kg CO2e, comprising about 8,516,600 kg CO2e from Scope 1 and about 249,380,640 kg CO2e from Scope 2 emissions. This marks a significant increase from 2023, where total emissions were about 208,280,090 kg CO2e, with Scope 1 emissions at approximately 4,898,000 kg CO2e and Scope 2 emissions at about 203,382,080 kg CO2e. Hengrui Pharma has set ambitious climate commitments, aiming for carbon neutrality by 2050. The company has established near-term reduction targets for both Scope 1 and Scope 2 emissions, with a focus on reducing carbon emissions during operations from 2023 to 2025. Additionally, a long-term roadmap was released, committing to peak carbon emissions by 2029. The emissions data is sourced from Jiangsu Hengrui Medicine Co., Ltd., and no Scope 3 emissions data has been disclosed. Hengrui Pharma's initiatives reflect a growing commitment to sustainability within the pharmaceutical industry, aligning with global climate action goals.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2021202220232024
Scope 1
8,837,680
0,000,000
0,000,000
0,000,000
Scope 2
235,222,570
000,000,000
000,000,000
000,000,000
Scope 3
-
-
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Hengrui Pharma's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Hengrui Pharma is in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Hengrui Pharma is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Roche Holding AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Sanofi

FR
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Pfizer

US
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Humanwell Healthcare (Group) Co.,Ltd.

CN
•
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

CellBion Co., Ltd.

KR
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251024.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy